Literature DB >> 24929239

Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema.

Nicolas Guyot1, Julien Wartelle1, Laurette Malleret1, Alexandre A Todorov1, Gilles Devouassoux2, Yves Pacheco3, Dieter E Jenne4, Azzaq Belaaouaj5.   

Abstract

Cigarette smoking is a major factor for the development of pulmonary emphysema because it induces abnormal inflammation and a protease-rich local milieu that causes connective tissue breakdown of the lungs. As a result of its capacity to degrade lung tissue and the high risk of patients lacking α1-antitrypsin to develop emphysema, much interest has focused on neutrophil elastase (NE). Two similar neutrophil serine proteases (NSPs), cathepsin G and proteinase 3, coexist with NE in humans and mice, but their potential tissue-destructive role(s) remains unclear. Using a gene-targeting approach, we observed that in contrast to their wild-type littermates, mice deficient in all three NSPs were substantially protected against lung tissue destruction after long-term exposure to cigarette smoke. In exploring the underlying basis for disrupted wild-type lung air spaces, we found that active NSPs collectively caused more severe lung damage than did NE alone. Furthermore, NSP activities unleashed increased activity of the tissue-destructive proteases macrophage elastase (matrix metalloproteinase-12) and gelatinase B (matrix metalloproteinase-9). These in vivo data provide, for the first time, compelling evidence of the collateral involvement of cathepsin G, NE, and proteinase 3 in cigarette smoke-induced tissue damage and emphysema. They also reveal a complex positive feed-forward loop whereby these NSPs induce the destructive potential of other proteases, thereby generating a chronic and pathogenic protease-rich milieu.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24929239     DOI: 10.1016/j.ajpath.2014.04.015

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Role for Cela1 in Postnatal Lung Remodeling and Alpha-1 Antitrypsin-Deficient Emphysema.

Authors:  Rashika Joshi; Andrea Heinz; Qiang Fan; Shuling Guo; Brett Monia; Christian E H Schmelzer; Anthony S Weiss; Matthew Batie; Harikrishnan Parameshwaran; Brian M Varisco
Journal:  Am J Respir Cell Mol Biol       Date:  2018-08       Impact factor: 6.914

2.  Single-Photon Emission Computed Tomography/Computed Tomography Imaging in a Rabbit Model of Emphysema Reveals Ongoing Apoptosis In Vivo.

Authors:  Monica P Goldklang; Yared Tekabe; Tina Zelonina; Jordis Trischler; Rui Xiao; Kyle Stearns; Alexander Romanov; Valeria Muzio; Takayuki Shiomi; Lynne L Johnson; Jeanine M D'Armiento
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

3.  Neutrophil-targeted, protease-activated pulmonary drug delivery blocks airway and systemic inflammation.

Authors:  Joscelyn C Mejías; Osric A Forrest; Camilla Margaroli; David A Frey Rubio; Liliana Viera; Jindong Li; Xin Xu; Amit Gaggar; Rabindra Tirouvanziam; Krishnendu Roy
Journal:  JCI Insight       Date:  2019-12-05

4.  HoxA9 transforms murine myeloid cells by a feedback loop driving expression of key oncogenes and cell cycle control genes.

Authors:  Xiaoxia Zhong; Andreas Prinz; Julia Steger; Maria-Paz Garcia-Cuellar; Markus Radsak; Abderrazzak Bentaher; Robert K Slany
Journal:  Blood Adv       Date:  2018-11-27

5.  Non-invasive profiling of protease-specific elastin turnover in lung cancer: biomarker potential.

Authors:  Jeppe Thorlacius-Ussing; Stephanie Nina Kehlet; Sarah Rank Rønnow; Morten Asser Karsdal; Nicholas Willumsen
Journal:  J Cancer Res Clin Oncol       Date:  2018-11-22       Impact factor: 4.553

6.  HIV infection model of chronic obstructive pulmonary disease in mice.

Authors:  Patrick Geraghty; Eran Hadas; Boe-Hyun Kim; Abdoulaye J Dabo; David J Volsky; Robert Foronjy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-19       Impact factor: 5.464

7.  N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3.

Authors:  Ioana Craciun; Amanda M Fenner; Robert J Kerns
Journal:  Glycobiology       Date:  2016-02-05       Impact factor: 4.313

8.  Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease.

Authors:  Katie M Stiles; Dolan Sondhi; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Ronald G Crystal
Journal:  Chronic Obstr Pulm Dis       Date:  2018-08-17

Review 9.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08

10.  TLR9 expression is required for the development of cigarette smoke-induced emphysema in mice.

Authors:  Robert F Foronjy; Matthias A Salathe; Abdoulaye J Dabo; Nathalie Baumlin; Neville Cummins; Edward Eden; Patrick Geraghty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-10       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.